Quantification of Alprenolol (cas 13655-52-2) and propranolol in human plasma using a two-dimensional liquid chromatography (2D-LC)
-
Add time:09/05/2019 Source:sciencedirect.com
A new two-dimensional liquid chromatography (2D-LC) method using a column switching valve, with a restricted-access media (RAM) column in the first dimension was developed and validated for the quantification of two β-blockers in human plasma. Several parameters, such as sample collection, mobile phase composition and flow rate for sample cleanup, transference and analytical separation of the β-blockers were investigated and optimized. The developed method allowed for the simultaneous pre-treatment and quantification of Alprenolol (cas 13655-52-2) (ALP) and propranolol (PRO) in human plasma in less than 25 min. The method consisted in the injection of 100 μL of plasma samples on the RAM alkyl-diol-silica column (Lichrospher® RP-18 ADS, 25 μm) with water/acetonitrile (98:2, v/v; at a flow rate of 2.0 mL/min) and then transferred (via a six-port valve) to the analytical column (Luna PFP (2), 150 × 4.6 mm ID, 100 Å, 3 μm) with 0.1% (v/v) triethylamine in water acidified with trifluoroacetic acid (pH = 3)/acetonitrile (74:26, v/v) at a flow rate of 0.6 mL/min in a back-flush mode. The column oven temperature was optimized to 42 °C and the fluorescence detector set at 280 nm and 310 nm (excitation and emission, respectively). The method was validated according to the European Medicines Agency’s guidelines and was linear (r2 > 0.999) over a dynamic range of 5.0 – 200 ng/mL. Recoveries ranged from 90.2 and 107% and the lower limit of quantification was 5.0 ng/mL for both compounds. Precision was expressed as a percentage of relative standard deviation and did not exceed 11%. Finally, the method was successfully applied to determine the plasma concentration of PRO in four healthy volunteers.
We also recommend Trading Suppliers and Manufacturers of Alprenolol (cas 13655-52-2). Pls Click Website Link as below: cas 13655-52-2 suppliers
Prev:Photochemistry of polymeric systems—VIII. Photo-crosslinking of polysiloxanes including cinnamic, furacrylic or α-cyano β-styrylacrylic ester groups: A comparative study☆
Next:Labeling of Alprenolol (cas 13655-52-2) with fluorescent aryl iodide as a reagent based on Mizoroki–Heck coupling reaction) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Combined pharmacokinetic and pharmacodynamic studies on Alprenolol (cas 13655-52-2) and 4-hydroxy-Alprenolol (cas 13655-52-2) in man09/27/2019
- Microcalorimetric studies on the complex formation between cellobiohydrolase I (CBH I) from Trichoderma reesei and the (R)- and (S)-enantiomers of the β-receptor blocking agent Alprenolol (cas 13655-52-2)09/26/2019
- Gel formulations containing catanionic vesicles composed of Alprenolol (cas 13655-52-2) and SDS: Effects of drug release and skin penetration on aggregate structure09/25/2019
- Regular paperAnalysis of the vasodilator action of Alprenolol (cas 13655-52-2)09/24/2019
- Nasal absorption of Alprenolol (cas 13655-52-2) and metoprolol09/10/2019
- Enantioselective determination of Alprenolol (cas 13655-52-2) in human plasma by liquid chromatography with tandem mass spectrometry using cellobiohydrolase chiral stationary phases09/09/2019
- Electrophoretic behavior of Alprenolol (cas 13655-52-2) in mixed solvent electrolyte systems09/08/2019
- Enantioselective biodegradation of pharmaceuticals, Alprenolol (cas 13655-52-2) and propranolol, by an activated sludge inoculum09/07/2019
- Labeling of Alprenolol (cas 13655-52-2) with fluorescent aryl iodide as a reagent based on Mizoroki–Heck coupling reaction09/06/2019